Medicine and Dentistry
Polycystic Ovary Syndrome
100%
Maturity Onset Diabetes of the Young
37%
Insulin Resistance
37%
Metabolic Syndrome
31%
Body Mass Index
25%
Diabetes
23%
Patient with Type 2 Diabetes
18%
Prevalence
17%
Hyperandrogenism
17%
Genome Wide Association Study
16%
Hemoglobin A1c
15%
Triacylglycerol
13%
Oral Glucose Tolerance Test
12%
Insulin Sensitivity
12%
High Density Lipoprotein Cholesterol
11%
Glycon
11%
Hormone Determination
10%
Antidiabetic Agent
10%
Bisphenol A
10%
Factor Analysis
9%
Premenopause
8%
Phthalic Acid
8%
Menstrual Cycle
8%
Oral Antidiabetic Agent
8%
Monotherapy
8%
Glycemic Control
8%
Heredity
7%
Oligomenorrhea
7%
Water-Electrolyte Imbalance
6%
Cardiovascular Risk
6%
Thyrotropin
6%
Uterine Fibroid
6%
Fine-Needle Aspiration
6%
Thyroid Gland
6%
Sustained Drug Release
6%
Placebo
6%
Genetic Risk
6%
Liotrix
6%
Calpain 10
6%
Diabetes Mellitus
6%
Homeostatic Model Assessment
6%
Body Weight
5%
Dyslipidemia
5%
Disease
5%
Haplotype
5%
Odds Ratio
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
57%
Ovary Polycystic Disease
37%
Insulin Resistance
30%
Hemoglobin A1c
26%
Diabetes Mellitus
24%
Metformin
17%
Hyperandrogenism
16%
Triacylglycerol
16%
Metabolic Syndrome X
16%
Prevalence
14%
High Density Lipoprotein Cholesterol
14%
Glimepiride
13%
Cardiovascular Disease
13%
Oral Antidiabetic Agent
11%
Antidiabetic Agent
11%
Impaired Glucose Tolerance
10%
4,4' Isopropylidenediphenol
10%
Placebo
10%
Oligomenorrhea
9%
Monotherapy
8%
Phthalic Acid
8%
Hirsutism
7%
Clinical Feature
7%
Adverse Event
7%
Metformin Plus Rosiglitazone
6%
Lobeglitazone
6%
Sustained Release
6%
Liotrix
6%
Muellerian Inhibiting Factor
6%
Genetic Risk
6%
Vitamin D Deficiency
6%
Somatomedin Binding Protein 3
6%
Udenafil
6%
Thyrotropin
6%
Erectile Dysfunction
6%
Adipocytokine
6%
Pioglitazone
6%
Diabetic Nephropathy
6%
Hypovitaminosis D
6%
Mitochondrial DNA
6%
Adiponectin
5%
Creatinine
5%
Kidney Disease
5%
Biochemistry, Genetics and Molecular Biology
Insulin Resistance
39%
Genome-Wide Association Study
35%
Body Mass
32%
Insulin Sensitivity
22%
Glucose Tolerance Test
16%
Glucose Test
16%
Single-Nucleotide Polymorphism
14%
Single Nucleotide Polymorphism
13%
Prevalence
11%
Gene Set Enrichment Analysis
11%
Case-Control Study
10%
Genetic Determinism
9%
Glucose Blood Level
9%
Triglyceride
8%
Dyslipidemia
8%
Menstruation
8%
Homeostasis
8%
Hyperglycemia
8%
Hostility
7%
Protein Tyrosine Phosphatase Receptor Delta
7%
Genetic Divergence
7%
Cohort Study
7%
Hypovitaminosis D
7%
Factor Analysis
6%
Blood Lipids
6%
Insulin-Like Growth Factor-Binding Protein
6%
Genetic Risk
6%
Fat Mass
6%
Lipid Storage
6%
Axon Guidance
6%
Focal Adhesion
6%
ITPR1
6%
Impulsiveness
6%
FGF10
6%
FHIT
6%
WNT7A
6%
Glimepiride
6%
Rosiglitazone
6%
Lipid Level
6%
Adipokine
6%
Adiponectin
6%
Hemoglobin Variant
6%
Testosterone
6%
Insulin Blood Level
5%
Creatinine
5%
Tumor Necrosis Factor
5%
Vitamin D
5%
Triacylglycerol Level
5%
Proband
5%
